“Using Regression Trees to Predict the Development of Immune-Mediated Adverse Events in Patients Receiving Immune Checkpoint Inhibitor Therapy”, Вопр. онкол., vol. 70, no. 4, pp. 677–684, Sep. 2024, doi: 10.37469/0507-3758-2024-70-4-677-684.